Position papers

Digital Trials and the Device Perimeter: A Regulatory Primer

A plain-language entry point to the regulatory questions raised by the devices and systems a clinical trial relies on — wearables and sensors, home and point-of-care instruments, apps and eCOA platforms, clinical systems, and the phones and tablets that connect them

Version
1.0
Length
6 pages

Abstract

Assess, rather than assume: a trial device’s regulatory status follows what it does, not what it is — and most assessments return a light-touch result that is then defensible. Teams most often misjudge the regulatory perimeter of the devices and systems a trial relies on. A participant’s phone is waved through as “just a phone”; a provisioned eCOA handset as “just the vendor’s phone”; a cleared spirometer or wearable as finished business because it is “already a device” — and the questions that actually attach get missed. One device or system can play several roles at once, so its obligations stack across seven regulated perimeters — medical device, GxP and computerized systems, data protection, human factors, configuration, economic operator and protocol design. They add up; they do not cancel out — and the stack differs per device and per deployment (Figure 1). What to do: for each device and system, establish its role, decide which perimeters it touches, record the controls and the reasoning, and reopen the assessment when the device, its software, its connection or the protocol changes. This primer names the seven perimeters and shows how the stack differs across three typical trial devices (Figure 1); Section 5 points to the paper that works each perimeter through, and QPP-00 — Regulatory Impact Assessment (RIA) sets out the method.

Contents

1. The moment a device or system carries trial data, regulatory questions attach to it; 2. A device’s regulatory status follows what it does, not what it is; 3. A trial device can fall into seven regulated perimeters at once; 4. Assess, rather than assume — and record the reasoning; 5. Start with QPP-00, then read the perimeters that match your devices and systems

Open access: no account, no form, no sales call.

#Decentralised trials

More from the library

Digital Health Technologies in Clinical Trials — A Regulatory Position-Paper Series

One device, several perimeters: a framework for assessing the regulatory impact of the technologies a trial relies on.

Read more →

Who Is the Manufacturer? Economic-Operator Roles in DHT Supply Chains

How provisioning, importing, kitting and modifying a device assign manufacturer, importer and distributor duties — often by operation of law.

Read more →

You Can Delegate the Work, Not the Accountability: Vendor Qualification and Oversight under ICH E6(R3)

The sponsor’s duty to qualify and oversee its DHT vendors — distinct from who holds the economic-operator role.

Read more →

Talk to a specialist

Bring one device and one protocol — a wearable, a sensor, an app, anything. We will tell you which regulatory perimeters it opens and what it takes to close them.

Book a 15-minute call